Department of Gastroenterology, University of Medicine and Pharmacy "Iuliu Hatieganu", 400347 Cluj-Napoca, Romania.
Regional Institute of Gastroenterology and Hepatology "O. Fodor", 400162 Cluj-Napoca, Romania.
Int J Mol Sci. 2023 Feb 9;24(4):3472. doi: 10.3390/ijms24043472.
Colitis-associated colo-rectal cancer remains the leading cause of mortality in inflammatory bowel diseases, with inflammation remaining one of the bridging points between the two pathologies. The NLRP3 inflammasome complex plays an important role in innate immunity; however, its misregulation can be responsible for the apparition of various pathologies such as ulcerative colitis. Our review focuses on the potential pathways of upregulation or downregulation of the NLRP3 complex, in addition to evaluating its role in the current clinical setting. Eighteen studies highlighted the potential pathways of NLRP3 complex regulation as well as its role in the metastatic process in colo-rectal cancer, with promising results. Further research is, however, needed in order to validate the results in a clinical setting.
结肠炎相关性结直肠癌仍然是炎症性肠病患者死亡的主要原因,炎症仍然是这两种病理之间的桥梁之一。NLRP3 炎性小体复合物在先天免疫中发挥着重要作用;然而,其失调可能导致各种疾病的出现,如溃疡性结肠炎。我们的综述重点介绍了 NLRP3 复合物上调或下调的潜在途径,以及其在当前临床环境中的作用。18 项研究强调了 NLRP3 复合物调节及其在结直肠癌转移过程中的作用的潜在途径,结果有很大的前景。然而,需要进一步的研究来验证临床环境中的结果。